Carrier-immobilized derivatized lysoganglioside GM1 is a ligand for specific binding sites in various human tumor cell types and peripheral blood lymphocytes and monocytes

This publication has 28 references indexed in Scilit:

• Chemical residues of ganglioside molecules involved in interactions with lymphocyte surface targets leading to CD4 masking and inhibition of mitogenic proliferation
  European Journal of Immunology, 1990
• ANIMAL GLYCOSPHINGOLIPIDS AS MEMBRANE ATTACHMENT SITES FOR BACTERIA
  Annual Review of Biochemistry, 1989
• Is the Profile of Binding of a Panel of Neoglycoproteins Useful as a Diagnostic Marker in Human Lung Cancer?
  Pathology - Research and Practice, 1989
• Is part of the molecular basis of the perineurial barrier function the lack of endogenous carbohydrate-binding proteins?
  Journal of Neuroscience Research, 1989
• Tumor Lectinology: At the Intersection of Carbohydrate Chemistry, Biochemistry, Cell Biology, and Oncology
  Angewandte Chemie International Edition in English, 1988
• N-hydroxysulfosuccinimide active esters: bis(N-hydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers
  Biochemistry, 1982
• Interactions of G_M1 Ganglioside with Crude Rat Brain Neuronal Membranes
  Journal of Neurochemistry, 1980
• Tissue distribution of EDTA encapsulated within liposomes containing glycolipids or brain phospholipids
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1978
• Comparison of the Interaction of Mono- and Oligovalent Ligands with Cholera Toxin. Demonstration of Aggregate Formation at Low Ligand Concentrations
  Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1978
• Biosynthesis and Function of Gangliosides
  Science, 1976